Talphera Inc (TLPH)

Currency in USD
1.0300
-0.0200(-1.90%)
Closed·
1.0139-0.0161(-1.56%)
·
TLPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.02001.0800
52 wk Range
0.38001.5700
Key Statistics
Prev. Close
1.05
Open
1.03
Day's Range
1.02-1.08
52 wk Range
0.38-1.57
Volume
291.84K
Average Volume (3m)
173.84K
1-Year Change
128.3814%
Book Value / Share
0.37
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TLPH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.1667
Upside
+207.44%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Talphera Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.1667
(+207.44% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy---New CoverageJun 05, 2026
WestPark Capital
Buy---New CoverageApr 30, 2026

Talphera Inc Earnings Call Summary for Q1/2026

  • Talphera reported Q1 2026 cash balance of $21.1M, boosted by $4.1M financing tranche, targeting operations through potential 2027 FDA approval.
  • Operating expenses surged 34.5% YoY to $3.9M in Q1 2026, driven by accelerated R&D activities for lead candidate Niyad in CRRT anticoagulation.
  • NEPHRO CRRT study enrollment exceeded 50% milestone; company targets enrollment completion by end-2026 with top-line data following shortly after.
  • Management plans PMA submission in 2026 for potential 2027 FDA approval; stock rose 4.94% aftermarket to $0.8999 on investor optimism.
  • Analysts set price targets of $3-$3.5 but note profitability not expected this year; financing tranche execution remains critical for operations.
Last Updated: 2026-05-13, 05:08 p/m
Read Full Transcript

Earnings

Latest Release
May 13, 2026
EPS / Forecast
-0.04 / -0.15
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TLPH Income Statement

Compare TLPH to Peers and Sector

Metrics to compare
TLPH
Peers
Sector
Relationship
P/E Ratio
−3.8x−9.7x−0.4x
PEG Ratio
−0.10−0.080.00
Price/Book
2.9x4.6x2.6x
Price / LTM Sales
53,456.6x12.8x3.0x
Upside (Analyst Target)
185.7%115.4%53.6%
Fair Value Upside
Unlock−2.7%7.6%Unlock

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company’s lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for disseminated intravascular coagulation, acute respiratory distress syndrome, acute pancreatitis, and an anti-viral treatment; Fedsyra, an ephedrine pre-filled syringe for injection; and a phenylephrine pre-filled syringe for injection. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.

Employees
12

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.01M1.94%1.06M
Other Institutional Investors
43.03M82.92%45.19M
Public Companies & Retail Investors
7.86M15.14%8.25M
Total
51.9M100.00%54.49M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
CorMedix Inc.17.52%9,090,9099,545
Aigh Capital Management, LLC8.98%4,661,5024,895

People Also Watch

26.65
BFb
-3.86%
0.597
ATYR
+5.30%
86.09
ZBH
-5.64%
2.9900
GLBS
-3.86%
31.430
CPRX
-0.10%

FAQ

What Is the Talphera (TLPH) Stock Price Today?

The Talphera stock price today is 1.0300 USD.

What Stock Exchange Does Talphera Trade On?

Talphera is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Talphera?

The stock symbol for Talphera is "TLPH."

What Is the Talphera Market Cap?

As of today, Talphera market cap is 53.4600M USD.

What Is Talphera's Earnings Per Share (TTM)?

The Talphera EPS (TTM) is -0.2674.

When Is the Next Talphera Earnings Date?

Talphera will release its next earnings report on Aug 19, 2026.

From a Technical Analysis Perspective, Is TLPH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Talphera Stock Split?

Talphera has split 1 times.

How Many Employees Does Talphera Have?

Talphera has 12 employees.

What is the current trading status of Talphera (TLPH)?

As of Jul 01, 2026, Talphera (TLPH) is trading at a price of 1.0300 USD, with a previous close of 1.0500 USD. The stock has fluctuated within a day range of 1.0200 USD to 1.0800 USD, while its 52-week range spans from 0.3800 USD to 1.5700 USD.

What Is Talphera (TLPH) Price Target According to Analysts?

The average 12-month price target for Talphera is 3.1667 USD, with a high estimate of 3.5 USD and a low estimate of 3 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +207.44% Upside potential.

What Is the TLPH Premarket Price?

TLPH's last pre-market stock price is 1.1083 USD. The pre-market share volume is 10.0000, and the stock has decreased by 0.0583, or 5.5500%.

What Is the TLPH After Hours Price?

TLPH's last after hours stock price is 1.0139 USD, the stock has decreased by -0.0161, or -1.5600%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.